Thyroid cancer

The following is a summary of "American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma" published in the ...

Tumors between 1 and 2 centimeters (between 6.8% and 18.9%) and 2 to 4 centimeters (between 6.6% and 16.0%) showed higher increases in TL rates than tumors under 1 centimeter (between 22.8% and 29.2%). Following the release of the 2009 guidelines and the release of the 2015 guidelines, the rate of adjuvant RAI among TT patients dropped from 48.7% to 37.1% and then to 19.3%, respectively. The prevalence of TL among surgical patients dropped from 15.1% to 13.7% after the 2009 recommendations but rose to 22.9% after the 2015 revisions. The primary objective was to compare the rates of total thyroidectomy (TT), total lobectomy (TL), and TL plus radioactive iodine (RAI) therapy before and after the 2009 and 2015 ATA guidelines. The rise in TL rates was greater in research hospitals (from 16.3% to 19.5%) than in community hospitals (from 14.9% to 25.7%). From the beginning of the study period to its end, a total of 194,254 individuals were identified (with 155,796 (80.2% of the total) being female patients) with a median [range] age at diagnosis of 51 (18-90) years.